DM

David J. Matlin

Chairman at Clene Nanomedicine

Mr. Matlin was the Chief Executive Officer of MatlinPatterson Global Advisers LLC, a global private equity firm, which he co-founded in 2002. David was a former Managing Director at Credit Suisse First Boston and also a founding partner of Merrion Group, LP. He currently serves on the public boards of MedTech Acquisition Partners (NASDAQ: MTAC) and the U.S. Well Service (NASDAQ: USWS), as well as privately held Dermasensor, Inc., Pristine Surgical, LLC, Traffk, LLC, and Empyrean Neuroscience, Inc. David holds a JD from the Law School of the University of California at Los Angeles and a BS from the Wharton School of the University of Pennsylvania.


Org chart

This person is not in the org chart


Teams


Offices

This person is not in any offices


Clene Nanomedicine

Clene is a clinical-stage biopharmaceutical company focused on the development of unique therapeutics for neurodegenerative diseases.


Industries

Employees

51-200

Links